AnaptysBio, Inc. (ANAB)
46.63
-0.77
(-1.62%)
USD |
NASDAQ |
Nov 20, 16:00
46.65
+0.02
(+0.04%)
After-Hours: 20:00
AnaptysBio Price : 46.63 for Nov. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | 47.48 | 47.71 | 46.05 | 46.63 | 432450.0 |
| Nov 19, 2026 | 48.41 | 49.71 | 46.86 | 47.40 | 507010.0 |
| Nov 18, 2026 | 45.59 | 47.18 | 44.83 | 47.06 | 567249.0 |
| Nov 17, 2026 | 45.81 | 46.19 | 44.99 | 45.61 | 598493.0 |
| Nov 16, 2026 | 45.78 | 46.23 | 44.69 | 45.73 | 483759.0 |
| Nov 13, 2026 | 45.27 | 47.36 | 44.64 | 46.25 | 499638.0 |
| Nov 12, 2026 | 48.23 | 48.86 | 47.68 | 47.77 | 262898.0 |
| Nov 11, 2026 | 49.00 | 49.16 | 47.81 | 48.77 | 230751.0 |
| Nov 10, 2026 | 47.63 | 48.66 | 47.10 | 48.38 | 244930.0 |
| Nov 09, 2026 | 47.03 | 48.96 | 46.19 | 47.97 | 323841.0 |
| Nov 06, 2026 | 45.85 | 46.63 | 45.01 | 46.45 | 287785.0 |
| Nov 05, 2026 | 47.51 | 47.74 | 45.47 | 45.58 | 380827.0 |
| Nov 04, 2026 | 49.00 | 49.00 | 45.81 | 47.51 | 528258.0 |
| Nov 03, 2026 | 47.36 | 48.35 | 47.36 | 47.73 | 304855.0 |
| Nov 02, 2026 | 48.33 | 48.37 | 46.90 | 46.91 | 281488.0 |
| Oct 30, 2026 | 48.68 | 48.97 | 47.88 | 48.28 | 293617.0 |
| Oct 29, 2026 | 50.85 | 51.22 | 48.33 | 48.64 | 414382.0 |
| Oct 28, 2026 | 49.59 | 50.55 | 49.00 | 50.50 | 309827.0 |
| Oct 27, 2026 | 49.24 | 50.02 | 48.70 | 49.63 | 349580.0 |
| Oct 26, 2026 | 48.97 | 49.62 | 47.98 | 48.77 | 417196.0 |
| Oct 23, 2026 | 48.19 | 48.88 | 47.05 | 48.73 | 468215.0 |
| Oct 22, 2026 | 47.65 | 48.51 | 46.83 | 48.10 | 254919.0 |
| Oct 21, 2026 | 45.48 | 48.48 | 45.48 | 47.94 | 664462.0 |
| Oct 20, 2026 | 49.57 | 51.86 | 44.02 | 45.43 | 1.206M |
| Oct 19, 2026 | 47.33 | 49.88 | 47.33 | 49.24 | 468355.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 5.97 |
| Amgen, Inc. | 435.64 |
| Anika Therapeutics, Inc. | 13.23 |
| BioCryst Pharmaceuticals, Inc. | 7.22 |
| Imunon, Inc. | 0.5355 |
Price Related Metrics
| PE Ratio | 7.726 |
| PS Ratio | 7.597 |
| Price to Book Value | 67.06 |
| Price to Free Cash Flow | 40.54 |
| Earnings Yield | 12.94% |
| Market Cap | 1.396B |
| Operating PE Ratio | 12.22 |
| Normalized PE Ratio | 7.726 |